Cargando…
Metabolomics of Type 1 and Type 2 Diabetes
Type 1 and type 2 diabetes mellitus (DM) are chronic diseases that affect nearly 425 million people worldwide, leading to poor health outcomes and high health care costs. High-throughput metabolomics screening can provide vital insight into the pathophysiological pathways of DM and help in managing...
Autores principales: | Arneth, Borros, Arneth, Rebekka, Shams, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566263/ https://www.ncbi.nlm.nih.gov/pubmed/31109071 http://dx.doi.org/10.3390/ijms20102467 |
Ejemplares similares
-
Activation of CD4+ and CD8+ T-lymphocytes by insulin and GAD in patients with type 1 or 2 diabetes mellitus
por: Arneth, Borros
Publicado: (2017) -
Neutrophil Extracellular Traps (NETs) and Vasculitis
por: Arneth, Borros, et al.
Publicado: (2021) -
Update on the types and usage of liquid biopsies in the clinical setting: a systematic review
por: Arneth, Borros
Publicado: (2018) -
Tumor Microenvironment
por: Arneth, Borros
Publicado: (2019) -
Neonatal Immune Incompatibilities between Newborn and Mother
por: Arneth, Borros
Publicado: (2020)